EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.21.73 | Abdominal Abscess |
19190912 |
Percutaneous treatment of intrabdominal abscess: urokinase versus saline serum in 100 cases using two surgical scoring systems in a randomized trial. |
diagnostic usage ongoing research therapeutic application unassigned |
2 4 4 0 |
3.4.21.73 | Abdominal Abscess |
19589548 |
[Utility of urokinase in percutaneous drainage treatment of intra-abdominal abscesses.] |
diagnostic usage ongoing research therapeutic application unassigned |
2 2 4 0 |
3.4.21.73 | Abortion, Habitual |
17156190 |
Could the defects in the endometrial extracellular matrix during the implantation be a cause for impaired fertility? |
causal interaction unassigned |
3 0 |
3.4.21.73 | Abscess |
2037395 |
Intraperitoneal thrombolytic agents in relapsing or persistent peritonitis of patients on continuous ambulatory peritoneal dialysis. |
diagnostic usage therapeutic application unassigned |
2 2 0 |
3.4.21.73 | Abscess |
3116952 |
Cutaneous infiltrates of histiocytosis X contain plasminogen activator-bearing epidermotropic dendritic cells different from Langerhans cells. |
ongoing research unassigned |
3 0 |
3.4.21.73 | Abscess |
7949709 |
Young Investigator Award. In vivo treatment of infected prosthetic graft material with urokinase: an animal model. |
therapeutic application unassigned |
1 0 |
3.4.21.73 | Abscess |
8416618 |
Fluid flow during percutaneous drainage procedures: an in vitro study of the effects of fluid viscosity, catheter size, and adjunctive urokinase. |
causal interaction therapeutic application unassigned |
2 1 0 |
3.4.21.73 | Abscess |
8416619 |
Safety of intracavitary urokinase with percutaneous abscess drainage. |
ongoing research therapeutic application unassigned |
4 1 0 |
3.4.21.73 | Abscess |
10435711 |
Adjuvant urokinase therapy in percutaneous drainage of a multiloculated splenic abscess. |
therapeutic application unassigned |
3 0 |
3.4.21.73 | Abscess |
10845505 |
Intracavitary urokinase for enhancement of percutaneous abscess drainage: phase II trial. |
diagnostic usage ongoing research therapeutic application unassigned |
2 3 4 0 |